Ottobock, Duderstadt, Germany, and Myomo, Cambridge, Massachusetts, have entered into an agreement for Ottobock to exclusively distribute Myomo’s patented MyoPro® orthosis technology globally, starting with select markets in North America and Germany.
“Ottobock is excited to leverage the strength of our global sales organization to represent this innovative treatment for the patients we serve,” said Frank Bomers, global head of orthotics for Ottobock.
“We are very pleased to enter into this agreement with Ottobock, a leader in the field of orthotics and prosthetics, so that we can broaden distribution of the MyoPro product line in the U.S. and in international markets served by Ottobock,” said Paul R. Gudonis, CEO of Myomo.
